Margaret Dugan Insider Profile
4 Followers
Margaret Dugan, Director at BeOne Medicines, holds 54.18K shares in BeOne Medicines (Ticker: ONC), holds 19.13K shares in Whitehawk Therapeutics (Ticker: WHWK), holds 24.57K shares in Schrodinger (Ticker: SDGR). Most recently, Margaret Dugan Sold ― shares of BeOne Medicines on May 27, 2026 for an estimated value of $65.64K.
Margaret Dugan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Margaret Dugan holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Margaret Dugan
Margaret Dugan's Trading History
BeOne Medicines
May 27, 2026
Director
Informative Sell
65.64K
$14.67M
Schrodinger
Oct 17, 2025
CMO
Uninformative Sell
29.38K
$353.87K
Whitehawk Therapeutics
May 18, 2026
CMO
Uninformative Buy
75.00K
$76.91K
List of latest transactions for each holding click on a transaction to see Margaret Dugan's performance on stock
You May Also Like
Margaret Dugan insider profile FAQ
What is the percentage of profitable transactions made by Margaret Dugan?
The percentage of profitable transactions made by Margaret Dugan is ―.
What is the average return per transaction made by Margaret Dugan?
The average return per transaction made by Margaret Dugan is ―.
What stocks does Margaret Dugan hold?
Margaret Dugan holds: ONC, SDGR, WHWK stocks.
What was Margaret Dugan’s latest transaction?
Margaret Dugan latest transaction was an Informative Sell of $65.64K.
What was Margaret Dugan's most profitable transaction?
Margaret Dugan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Margaret Dugan's role in BeOne Medicines?
Margaret Dugan's role in BeOne Medicines is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.